Variant report
Variant | nsv557964 |
---|---|
Chromosome Location | chr12:29956687-29971416 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181173956 | chr12:29958857-29958858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370169752 | chr12:29958859-29958860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527694249 | chr12:29958926-29958927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377459228 | chr12:29958929-29958930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549056596 | chr12:29958951-29958952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186535526 | chr12:29958965-29958966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537625606 | chr12:29958987-29958988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546372740 | chr12:29959098-29959099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545460452 | chr12:29959099-29959100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs74237104 | chr12:29959122-29959123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7296907 | chr12:29959123-29959124 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs11050447 | chr12:29959145-29959146 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs554047378 | chr12:29959172-29959173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550864751 | chr12:29959231-29959232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11613161 | chr12:29959233-29959234 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs542694358 | chr12:29959261-29959262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539450199 | chr12:29959271-29959272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11050448 | chr12:29959294-29959295 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs11050449 | chr12:29959296-29959297 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs543558533 | chr12:29959306-29959307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs74647610 | chr12:29959344-29959345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557689922 | chr12:29959375-29959376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533574275 | chr12:29959418-29959419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139836950 | chr12:29959427-29959428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200949510 | chr12:29959448-29959449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs527675086 | chr12:29959487-29959488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548991136 | chr12:29959508-29959509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561028041 | chr12:29959520-29959521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs142048886 | chr12:29959532-29959533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549882589 | chr12:29959533-29959534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191002155 | chr12:29959562-29959563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs151230967 | chr12:29959563-29959564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534329800 | chr12:29959600-29959601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547374159 | chr12:29959601-29959602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565996607 | chr12:29959621-29959622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575566914 | chr12:29959655-29959656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544354793 | chr12:29959659-29959660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554571411 | chr12:29959669-29959670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576130031 | chr12:29959674-29959675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369003 | chr12:29959697-29959698 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs558627381 | chr12:29959702-29959703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs11050450 | chr12:29959752-29959753 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs545630353 | chr12:29959768-29959769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560599000 | chr12:29959787-29959788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544451708 | chr12:29959789-29959790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182400028 | chr12:29959794-29959795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556901851 | chr12:29959795-29959796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560916921 | chr12:29959806-29959807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs11050451 | chr12:29959812-29959813 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs549999535 | chr12:29959815-29959816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Osteosarcoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:29958800-29960000 | Enhancers | Muscle Satellite Cultured Cells | -- |
2 | chr12:29959200-29959800 | Enhancers | Hela-S3 | cervix |
3 | chr12:29959600-29960000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr12:29959800-29960200 | Weak transcription | Hela-S3 | cervix |
5 | chr12:29959800-29960600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr12:29960200-29962600 | Enhancers | Hela-S3 | cervix |
7 | chr12:29960400-29960800 | Enhancers | HepG2 | liver |
8 | chr12:29960800-29961800 | Weak transcription | HepG2 | liver |
9 | chr12:29961800-29962000 | Enhancers | HepG2 | liver |
10 | chr12:29970400-29970800 | Enhancers | Lung | lung |
11 | chr12:29970600-29970800 | Enhancers | Right Ventricle | heart |
12 | chr12:29970600-29972200 | Enhancers | Fetal Muscle Leg | muscle |
13 | chr12:29970800-29971400 | Weak transcription | Right Ventricle | heart |
14 | chr12:29971200-29973800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr12:29971400-29972000 | Enhancers | Left Ventricle | heart |
16 | chr12:29971400-29972200 | Enhancers | Right Ventricle | heart |